retatrutide triple hormone receptor agonist Phase 2 Trial of for Obesity Triple hormone receptor agonist retatrutide

Clinical trial results and real-world use paint a consistent side effect profile, the majority of which is mild and easily managed

If you or a loved one suffered from severe stomach paralysis, bowel obstruction, ileus, or other health issues after taking Ozempic, you may be eligible to file an Ozempic lawsuit against the drug makers

PGX Fibers, from Natural Factors, has clinical research showing GLP-1 stability and reduced blood sugar

Clinical studies show that GLP-1 receptor agonists improve psoriasis severity scores regardless of whether the patient has diabetes

For many people, the transition off the medication or to lower maintenance dosing is also important

Exendin-4 was eventually developed into exenatide, a treatment for diabetes and the first GLP-1 receptor agonist approved for medical use